BRAF mutations in colorectal carcinoma suggest two entities of microsatellite‐unstable tumors

• Published in: Cancer 2005-09, Vol.104 (5), p.952-961
• Main Authors: Lubomierski, Nikolaus, Plotz, Guido, Wormek, Marc, Engels, Knut, Kriener, Susanne, Trojan, Jorg, Jungling, Bernd, Zeuzem, Stefan, Raedle, Jochen
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Biological and medical sciences; Carrier Proteins; colorectal carcinomas; colorectal neoplasms; Colorectal Neoplasms - genetics; DNA Methylation; DNA Repair; DNA-Binding Proteins - genetics; Female; Gastroenterology. Liver. Pancreas. Abdomen; hereditary nonpolyposis; Humans; Immunohistochemistry; Male; Medical sciences; Microsatellite Repeats; Middle Aged; Mutation; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins - genetics; Nuclear Proteins - genetics; Phenotype; Promoter Regions, Genetic; Proto-Oncogene Proteins - genetics; Proto-Oncogene Proteins B-raf - genetics; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Tumors
• ISSN: 0008-543X; 1097-0142
• DOI: 10.1002/cncr.21266

BACKGROUND Alterations of BRAF have been implicated in the carcinogenesis of colorectal tumors with microsatellite instability (MSI). These alterations were attributed to defective DNA mismatch repair, which underlies MSI. It was the objective of this study to clarify the role of BRAF in colorectal carcinoma with MSI. METHODS After sequencing for BRAF and KRAS in 82 colorectal tumor samples with or without MSI, mismatch repair protein expression was analyzed by immunohistochemistry, and promoter methylation of hMLH1 was analyzed with a methylation‐specific polymerase chain reaction. Results were correlated with the germline status of hMLH1 or hMSH2 and clinical characteristics. RESULTS BRAF was mutated more often in tumors with MSI than in tumors without MSI (27% vs. 5%; P = 0.016). The most prevalent BRAF alteration, V599E, occurred only in tumors with MSI. BRAF V599E was associated with more frequent hMLH1 promoter methylation (P = 0.07) and loss of hMLH1 (P = 0.02). The median age of patients with BRAF V599E was older compared with the median age of patients without this mutation (P = 0.001; 78 vs. 49 yrs). No BRAF alterations occurred in patients with germline mutations of mismatch repair genes. Five novel BRAF mutations were identified. CONCLUSIONS Although BRAF V599E was common in colorectal carcinomas with MSI, it was not a consequence of deficient mismatch repair. The current data showed instead that the BRAF V599E mutation was associated only with a subgroup of colorectal carcinomas with MSI that were obtained from older patients without hereditary nonpolyposis colorectal carcinoma and showed epigenetic silencing of hMLH1. These results indicated that tumors with MSI caused by epigenetic MLH1 silencing have a distinct mutational background from that of tumors with genetic loss of mismatch repair, suggesting that there are two genetically distinct entities of microsatellite‐instable tumors. Cancer 2005. © 2005 American Cancer Society. The BRAF V599E mutation in colorectal carcinoma was associated not only with microsatellite instability (MSI) but also with epigenetic hMLH1 silencing and older patient age at the time of tumor diagnosis. These results suggest that colorectal carcinomas with MSI can be divided in two genetically distinct entities, one of which typically exhibits this BRAF mutation.